98%
921
2 minutes
20
In South Korea, domestic cattle, pigs, and goats were subjected to mandatory foot-and-mouth disease (FMD) vaccination and year-round serosurveillance since 2011. In 2020, approximately USD 95 million was spent solely for FMD vaccine purchase for 59 million livestock, and 1.25 million samples were tested to estimate the population immunity and demonstrate the absence of virus circulation. As the FMD vaccination program was revised in 2018, the post-vaccination monitoring (PVM) was designed to evaluate the effectiveness of the vaccine program of three vaccines approved for routine use. To this end, monitoring post-vaccination immunity has been conducted by collecting 35,626 serum samples at 28 days post-vaccination following regular national vaccinations, which were carried out in April and in October in 2020. The design of the serological test for PVM was specially targeted at particular livestock groups, including dairy cattle, goats, and beef cattle aged 6-12 months, which were generally estimated to have a low expected seroprevalence. The risk factors had also been identified, considering the increased likelihood of infection in a particular location, herd size, and husbandry system applied in a targeted sample collection. Serum sample collection and SP-O and NSP antibody tests were performed by local veterinary laboratories using commercially available ELISAs. The current FMD vaccination program, which was performed twice a year following the regimen of primary vaccination and boost, resulted in over 80% population immunity. The seroprevalence monitored after the vaccination in fall was higher than the one studied in spring except in pigs. It was demonstrated that the seroprevalence of risk-based targeted samples ranged from 93.8 to 100% in cattle, 63.2 to 100% in pigs, and 20.0 to 100% in goats. Of note is the area near the North Korean borders which showed a relatively low seroprevalence among the targeted regions, and no NSP sero-positive reactor was detected in this region. When subpopulation immunity at the individual level was assessed, the seroprevalence in young cattle stock was slightly lower (95.8%) than that of adults (98.4%). In conclusion, the FMD vaccination campaign has been successfully implemented in Korea, and the PVM can be a supplementary program for massive routine surveillance in terms of providing timely information needed both to estimate population immunity and to properly target "risk-based surveillance."
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371437 | PMC |
http://dx.doi.org/10.3389/fvets.2021.673820 | DOI Listing |
Animals (Basel)
August 2025
Environment Authority, Muscat 100, Oman.
The Sultanate of Oman boasts remarkable biodiversity, exemplified by such species as the Arabian leopard () and the Arabian oryx (), national symbols that highlight the extensive conservation efforts required to protect the country's natural heritage. During decades, Omani authorities have taken significant measures to safeguard wildlife and preserve the natural environment. A sanctuary dedicated to the reintroduction of the Arabian Oryx, after extinction in nature in 1972, was established in 1980 in the Al Wusta Governorate under the patronage of the Royal Diwan and currently administrated by the recently established Environment Authority.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
ICAR-National Institute on Foot and Mouth Disease, International Centre for Foot and Mouth Disease, Bhubaneswar, India.
Foot-and-mouth disease (FMD) is one of the most significant animal diseases globally, affecting over 60 susceptible species including camelids particularly Bactrian camels. In order to gather baseline evidence on the current status of FMD in Indian camels, a preliminary random serosurvey was conducted in camels of Rajasthan state with significant camel population. A total of 777 sera collected from one-humped dromedary camels () across 11 districts of Rajasthan during 2016-2017 were screened for FMD virus (FMDV) 3ABC nonstructural protein (NSP)-antibodies using the commercial PrioCHECK FMDV NS kit.
View Article and Find Full Text PDFMed Hist
August 2025
Université Paris-Saclay, Études sur les Sciences et les Techniques (EST), 91 400Orsay, France.
Following the trajectories of vaccines against foot-and-mouth disease (FMD) in France and Britain up to the 1960s, this paper will show how vaccine efficacy has two meanings: 1) technical - or - which refers to test protocols and regimes of evidence, and 2) practical - or - which refers to the experience various actors have of diseases and their direct or indirect impacts on society and the economy, as well as on representations and imaginaries they share about diseases, vaccines, and vaccination. The assessment protocols in the two countries are analysed to show how these two meanings are deeply intertwined and influence the different public policies chosen by each country. Although statistically assessed, the efficacy of the same vaccines appears situated, depending not only on regimes of evidence but also on the reality of agricultural practices, on national stock exchanges, and on various imaginaries about animal health and the absence of disease that differ between and within countries.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Foot-and-mouth disease is an important transboundary animal disease with a significant economic impact. The high mutation rate of the foot-and-mouth disease virus leads to the emergence of new genotypes, which necessitate the detection, identification and surveillance of FMD. The current study was conducted to detect and characterize the circulating FMD viruses in Iran between November 2019 and September 2023, based on the VP1 sequence analysis.
View Article and Find Full Text PDFPrev Vet Med
November 2025
EpiCentre, School of Veterinary Science, Massey University, Palmerston North, New Zealand.
Foot-and-mouth disease virus (FMDV) serotype Asia 1 has not been reported in Southeast Asia, China and Mongolia between 2018 and 2024, despite the endemicity of FMD in this region and the continued circulation of serotype Asia 1 in South Asia. While vaccines against Asia 1 are still occasionally used in this region, it is unknown whether the absence of reports indicates true disease freedom or surveillance gaps. This study aimed to estimate the sensitivity of existing passive surveillance systems, and the probability of regional freedom from serotype Asia 1 across eight countries using the scenario tree approach.
View Article and Find Full Text PDF